Dancitaz belongs to a group of drugs with effects on blood, often used in the treatment of ischemic cases such as diabetic peripheral vascular disease, occlusive arteriosclerosis, ...

Molantel's main ingredient is Cilostazol, which belongs to the group of platelet aggregation inhibitors and vasodilators. Molantel is indicated for the treatment of intermittent claudication due to chronic lower limb arterial disease to improve maximum walking distance for walkers.